Summary
A 42-year-old defense contractor was granted a security clearance after addressing concerns under Guideline H (Drug Involvement). The Statement of Reasons focused on the applicant's past drug involvement and substance misuse. Disqualifying conditions were raised under AG ¶ 25(a), AG ¶ 25(c), AG ¶ 25(f), and AG ¶ 25(g).
The administrative judge determined that the applicant had successfully mitigated these concerns. The applicant's last use of marijuana was in December 2016, demonstrating a significant period of abstinence. He provided credible testimony about his commitment to abstain from illegal drugs in the future, citing his dedication to his family and job.
Furthermore, the applicant's full disclosure of his past drug use during the security clearance process enhanced his credibility. The judge concluded that the applicant's past behavior does not undermine his current reliability and trustworthiness, leading to the decision to grant the security clearance.
Why the Applicant Prevailed
- The applicant has not used marijuana since December 2016, demonstrating a significant period of abstinence.
- He credibly testified about his intention to avoid illegal drugs in the future, emphasizing his commitment to his family and job.
- The applicant's full disclosure of his drug use during the security clearance process bolstered his credibility.
Conditions Referenced
- AG ¶ 25(a)raisedAny Substance Misuse
- AG ¶ 25(c)raisedIllegal Possession of a Controlled Substance
- AG ¶ 25(f)raisedIllegal Drug Use While Granted Access to Classified Information
- AG ¶ 25(g)raisedExpressed Intent to Continue Drug Involvement
- AG ¶ 26(a)appliedBehavior Happened so Long Ago
- AG ¶ 26(b)appliedAcknowledgment of Drug Involvement and Pattern of Abstinence
Key Rule Quoted
“The protection of the national security is the paramount consideration.”
Procedural Posture
- SOR issuedApr 14, 2021
- Answer filedMay 11, 2021
- Hearing heldNov 4, 2021
- Decision dateNov 16, 2021
Cite For
- Mitigation of Drug Involvement Under Guideline H
- Importance of Credible Testimony Regarding Future Drug Use
- Weight of Full Disclosure in Security Clearance Proceedings